Search results

123 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
"Waging War on Cancer"
Winston-Salem Journal Editorial, August 8, 2007
Located in News / 2011 News
2013-2014 University Cancer Research Fund Annual Report now available
The UCRF, a $42 million, state-appropriated fund established in 2007, continues to have a significant impact on cancer research in North Carolina.
Located in News
2014 University Cancer Research Fund Innovation Awards announced
Six researchers have been awarded 2014 University Cancer Research Fund (UCRF) Innovation Awards for promoting innovative and new ideas in cancer research at the University of North Carolina at Chapel Hill.
Located in News
A powerful technique to further understanding of RNA
Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.
Located in News
Basch calls for more data on prostate cancer detection technology in JAMA editorial
A UNC Lineberger researcher has pointed to a need for more data on whether new technology designed to better detect men at higher-risk for prostate cancer will also mean improvements in survival rates and symptoms.
Located in News
Basch contributes to new ASCO guidelines for prostate cancer treatment
New clinical guidelines have been announced for the treatment of men with metastatic castration-resistant prostate cancer (CRPC) by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO). Ethan Basch, MD, director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, served as the co-chair of the ASCO/CCO expert panel that developed the guideline.
Located in News
Breast cancer prevention drug benefit varies among at-risk women, study finds
After weighing the risk of serious side effects with the benefits of a breast cancer prevention drug, a study led by a University of North Carolina at Chapel Hill researcher found that the drug’s benefits outweighed risks for most, but not all women.
Located in News
Carey named newly elected member of ASCO Nominating Committee
Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital, has been named to the American Society of Clinical Oncology (ASCO) Nominating Committee. An ASCO member since 1997, Carey will serve a three-year term on the committee.
Located in News
Carolina Breast Cancer Study enrolls record 3,000 participants
The largest-ever population-based study of breast cancer in North Carolina is poised to begin the five year follow-up phase.
Located in News
Changing the face of clinical trials
UNC Lineberger secures three major NCI grants to advance the nation’s clinical trials program.
Located in News